Global Vaccine Contract Manufacturing Market By Vaccine Type (Inactivated Vaccines, Attenuated Vaccines, RNA Vaccines, Subunit Vaccines, and Toxoid-based Vaccines), By Process (Downstream (Analytical & QC Studies, Fill and Finish, Packaging, Others) and Upstream (Bacterial Expression Systems, Baculovirus/Insect Expression Systems, Mammalian Expression Systems, Yeast Expression Systems, Others)), By Scale of Operations (Preclinical, Clinical, and Commercial), By End-use (Human Use and Veterinary), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024-2033

Published date: Oct 2024
Report ID: 131375
Number of Pages:
Format:

Table of Contents
- 1. Executive Summary
  - 1.1. Definition
  - 1.2. Market Snapshot
  - 1.3. Market Overview
  - 1.4. Segment Overview
  - 1.5. Regional Overview
  - 1.6. Competitive Landscape
  - 1.7. Taxonomy
- 2. Global Market Overview
  - 2.1. Global Market Insights and Industry Overview
  - 2.2. Market Dynamics
    2.2.1. Drivers
    2.2.2. Restraints
    2.2.3. Opportunities
    2.2.4. Key Vaccine Contract Manufacturing Market Trends
  - 2.3. Regulatory Framework
  - 2.4. Opportunity Map Analysis
  - 2.5. Opportunity Orbits
  - 2.6. PESTLE Analysis
  - 2.7. PORTER’S Five Force Analysis
  - 2.8. Drivers & Restraints Impact Analysis
  - 2.9. Value Chain Analysis
    2.9.1. List of Raw Materials Suppliers
    2.9.2. List of Vaccine Contract Manufacturing Manufacturers
    2.9.3. List of Dealer/Distributors
  - 2.10. Regional Market Share and BPS Analysis
  - 2.11. Impact of Macro-economic Factors/Geopolitical Factors
- 3. Global Vaccine Contract Manufacturing Market Analysis and Forecast, By Segment, 2019-2033
  - 3.1. Key Findings
  - 3.2. Global Vaccine Contract Manufacturing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Vaccine Type, 2019-2033
  - 3.3. Global Vaccine Contract Manufacturing Market Attractiveness Analysis, By Vaccine Type
    3.3.1. Inactivated Vaccines
    3.3.1.1. Insights
    3.3.1.2. Key Takeaways
    3.3.2. Attenuated Vaccines
    3.3.2.1. Insights
    3.3.2.2. Key Takeaways
    3.3.3. RNA Vaccines
    3.3.3.1. Insights
    3.3.3.2. Key Takeaways
    3.3.4. Subunit Vaccines
    3.3.4.1. Insights
    3.3.4.2. Key Takeaways
    3.3.5. Toxoid-based Vaccines
    3.3.5.1. Insights
    3.3.5.2. Key Takeaways
  - 3.4. Global Vaccine Contract Manufacturing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Process, 2019-2033
  - 3.5. Global Vaccine Contract Manufacturing Market Attractiveness Analysis, By Process
    3.5.1. Downstream
    3.5.1.1. Insights
    3.5.1.2. Key Takeaways
    3.5.1.2.1. Analytical & QC Studies
    3.5.1.2.2. Fill and Finish
    3.5.1.2.3. Packaging
    3.5.1.2.4. Others
    3.5.2. Upstream
    3.5.2.1. Insights
    3.5.2.2. Key Takeaways
    3.5.2.2.1. Bacterial Expression Systems
    3.5.2.2.2. Baculovirus/Insect Expression Systems
    3.5.2.2.3. Mammalian Expression Systems
    3.5.2.2.4. Yeast Expression Systems
    3.5.2.2.5. Others
  - 3.6. Global Vaccine Contract Manufacturing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Scale of Operations, 2019-2033
  - 3.7. Global Vaccine Contract Manufacturing Market Attractiveness Analysis, By Scale of Operations
    3.7.1. Preclinical
    3.7.1.1. Insights
    3.7.1.2. Key Takeaways
    3.7.2. Clinical
    3.7.2.1. Insights
    3.7.2.2. Key Takeaways
    3.7.3. Commercial
    3.7.3.1. Insights
    3.7.3.2. Key Takeaways
  - 3.8. Global Vaccine Contract Manufacturing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-use, 2019-2033
  - 3.9. Global Vaccine Contract Manufacturing Market Attractiveness Analysis, By End-use
    3.9.1. Human Use
    3.9.1.1. Insights
    3.9.1.2. Key Takeaways
    3.9.2. Veterinary
    3.9.2.1. Insights
    3.9.2.2. Key Takeaways
- 4. Global Vaccine Contract Manufacturing Market Analysis and Forecast, By Region, 2019-2033
  - 4.1. Key Findings
  - 4.2. Global Vaccine Contract Manufacturing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Region, 2019-2033
    4.2.1. North America
    4.2.1.1. Regional Insights
    4.2.2. Europe
    4.2.2.1. Regional Insights
    4.2.3. Asia Pacific
    4.2.3.1. Regional Insights
    4.2.4. Latin America
    4.2.4.1. Regional Insights
    4.2.5. Middle East & Africa
    4.2.5.1. Regional Insights
  - 4.3. Global Vaccine Contract Manufacturing Market Attractiveness Analysis, By Region
- 5. North America Vaccine Contract Manufacturing Market Analysis and Forecast, 2019-2033
  - 5.1. Key Findings
  - 5.2. North America Vaccine Contract Manufacturing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Vaccine Type, 2019-2033
  - 5.3. North America Vaccine Contract Manufacturing Market Attractiveness Analysis, By Vaccine Type
  - 5.4. North America Vaccine Contract Manufacturing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Process, 2019-2033
  - 5.5. North America Vaccine Contract Manufacturing Market Attractiveness Analysis, By Process
  - 5.6. North America Vaccine Contract Manufacturing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Scale of Operations, 2019-2033
  - 5.7. North America Vaccine Contract Manufacturing Market Attractiveness Analysis, By Scale of Operations
  - 5.8. North America Vaccine Contract Manufacturing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-use, 2019-2033
  - 5.9. North America Vaccine Contract Manufacturing Market Attractiveness Analysis, By End-use
  - 5.10. North America Vaccine Contract Manufacturing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2019-2033
  - 5.11. North America Vaccine Contract Manufacturing Market Attractiveness Analysis, By Country
    5.11.1. The US
    5.11.2. Canada
- 6. Europe Vaccine Contract Manufacturing Market Analysis and Forecast, 2019-2033
  - 6.1. Key Findings
  - 6.2. Europe Vaccine Contract Manufacturing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Vaccine Type, 2019-2033
  - 6.3. Europe Vaccine Contract Manufacturing Market Attractiveness Analysis, By Vaccine Type
  - 6.4. Europe Vaccine Contract Manufacturing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Process, 2019-2033
  - 6.5. Europe Vaccine Contract Manufacturing Market Attractiveness Analysis, By Process
  - 6.6. Europe Vaccine Contract Manufacturing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Scale of Operations, 2019-2033
  - 6.7. Europe Vaccine Contract Manufacturing Market Attractiveness Analysis, By Scale of Operations
  - 6.8. Europe Vaccine Contract Manufacturing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-use, 2019-2033
  - 6.9. Europe Vaccine Contract Manufacturing Market Attractiveness Analysis, By End-use
  - 6.10. Europe Vaccine Contract Manufacturing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2019-2033
  - 6.11. Europe Vaccine Contract Manufacturing Market Attractiveness Analysis, By Country
    6.11.1. Germany
    6.11.2. The UK
    6.11.3. France
    6.11.4. Spain
    6.11.5. Italy
    6.11.6. Russia
    6.11.7. Netherland
    6.11.8. Rest of Europe
- 7. Asia Pacific Vaccine Contract Manufacturing Market Analysis and Forecast, 2019-2033
  - 7.1. Key Findings
  - 7.2. Asia Pacific Vaccine Contract Manufacturing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Vaccine Type, 2019-2033
  - 7.3. Asia Pacific Vaccine Contract Manufacturing Market Attractiveness Analysis, By Vaccine Type
  - 7.4. Asia Pacific Vaccine Contract Manufacturing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Process, 2019-2033
  - 7.5. Asia Pacific Vaccine Contract Manufacturing Market Attractiveness Analysis, By Process
  - 7.6. Asia Pacific Vaccine Contract Manufacturing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Scale of Operations, 2019-2033
  - 7.7. Asia Pacific Vaccine Contract Manufacturing Market Attractiveness Analysis, By Scale of Operations
  - 7.8. Asia Pacific Vaccine Contract Manufacturing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-use, 2019-2033
  - 7.9. Asia Pacific Vaccine Contract Manufacturing Market Attractiveness Analysis, By End-use
  - 7.10. Asia Pacific Vaccine Contract Manufacturing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2019-2033
  - 7.11. Asia Pacific Vaccine Contract Manufacturing Market Attractiveness Analysis, By Country
    7.11.1. China
    7.11.2. Japan
    7.11.3. South Korea
    7.11.4. India
    7.11.5. Australia
    7.11.6. New Zealand
    7.11.7. Singapore
    7.11.8. Thailand
    7.11.9. Vietnam
    7.11.10. Rest of Asia Pacific
- 8. Latin America Vaccine Contract Manufacturing Market Analysis and Forecast, 2019-2033
  - 8.1. Key Findings
  - 8.2. Latin America Vaccine Contract Manufacturing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Vaccine Type, 2019-2033
  - 8.3. Latin America Vaccine Contract Manufacturing Market Attractiveness Analysis, By Vaccine Type
  - 8.4. Latin America Vaccine Contract Manufacturing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Process, 2019-2033
  - 8.5. Latin America Vaccine Contract Manufacturing Market Attractiveness Analysis, By Process
  - 8.6. Latin America Vaccine Contract Manufacturing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Scale of Operations, 2019-2033
  - 8.7. Latin America Vaccine Contract Manufacturing Market Attractiveness Analysis, By Scale of Operations
  - 8.8. Latin America Vaccine Contract Manufacturing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-use, 2019-2033
  - 8.9. Latin America Vaccine Contract Manufacturing Market Attractiveness Analysis, By End-use
  - 8.10. Latin America Vaccine Contract Manufacturing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2019-2033
  - 8.11. Latin America Vaccine Contract Manufacturing Market Attractiveness Analysis, By Country
    8.11.1. Brazil
    8.11.2. Mexico
    8.11.3. Rest of Latin America
- 9. Middle East & Africa Vaccine Contract Manufacturing Market Analysis and Forecast, 2019-2033
  - 9.1. Key Findings
  - 9.2. Middle East & Africa Vaccine Contract Manufacturing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Vaccine Type, 2019-2033
  - 9.3. Middle East & Africa Vaccine Contract Manufacturing Market Attractiveness Analysis, By Vaccine Type
  - 9.4. Middle East & Africa Vaccine Contract Manufacturing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Process, 2019-2033
  - 9.5. Middle East & Africa Vaccine Contract Manufacturing Market Attractiveness Analysis, By Process
  - 9.6. Middle East & Africa Vaccine Contract Manufacturing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Scale of Operations, 2019-2033
  - 9.7. Middle East & Africa Vaccine Contract Manufacturing Market Attractiveness Analysis, By Scale of Operations
  - 9.8. Middle East & Africa Vaccine Contract Manufacturing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-use, 2019-2033
  - 9.9. Middle East & Africa Vaccine Contract Manufacturing Market Attractiveness Analysis, By End-use
  - 9.10. Middle East & Africa Vaccine Contract Manufacturing Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2019-2033
  - 9.11. Middle East & Africa Vaccine Contract Manufacturing Market Attractiveness Analysis, By Country
    9.11.1. South Africa
    9.11.2. Saudi Arabia
    9.11.3. UAE
    9.11.4. Rest of Middle East & Africa
- 10. Competitive Landscape & Company Profiles
  - 10.1. Market Competition Scenario Analysis, By Company
    10.1.1. Key Takeaways
  - 10.2. Overview of Major Market Players
  - 10.3. Competitor Landscape
  - 10.4. Strategic Mapping
  - 10.5. Company Life Cycle Analysis
  - 10.6. Company Market Share Analysis
  - 10.7. Company Profiles
    10.7.1. PRA Health Sciences
    10.7.1.1. Company Details
    10.7.1.2. Business Overview
    10.7.1.3. Product Portfolio
    10.7.1.4. Financial Insights
    10.7.1.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    10.7.1.6. SWOT Analysis
    10.7.1.7. Geographic Footprint
    10.7.2. Pharmaceutical Product Development, LLC
    10.7.2.1. Company Details
    10.7.2.2. Business Overview
    10.7.2.3. Product Portfolio
    10.7.2.4. Financial Insights
    10.7.2.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    10.7.2.6. SWOT Analysis
    10.7.2.7. Geographic Footprint
    10.7.3. Moderna
    10.7.3.1. Company Details
    10.7.3.2. Business Overview
    10.7.3.3. Product Portfolio
    10.7.3.4. Financial Insights
    10.7.3.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    10.7.3.6. SWOT Analysis
    10.7.3.7. Geographic Footprint
    10.7.4. Merck KgaA
    10.7.4.1. Company Details
    10.7.4.2. Business Overview
    10.7.4.3. Product Portfolio
    10.7.4.4. Financial Insights
    10.7.4.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    10.7.4.6. SWOT Analysis
    10.7.4.7. Geographic Footprint
    10.7.5. IDT Biologika GmbH
    10.7.5.1. Company Details
    10.7.5.2. Business Overview
    10.7.5.3. Product Portfolio
    10.7.5.4. Financial Insights
    10.7.5.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    10.7.5.6. SWOT Analysis
    10.7.5.7. Geographic Footprint
    10.7.6. ICON plc.
    10.7.6.1. Company Details
    10.7.6.2. Business Overview
    10.7.6.3. Product Portfolio
    10.7.6.4. Financial Insights
    10.7.6.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    10.7.6.6. SWOT Analysis
    10.7.6.7. Geographic Footprint
    10.7.7. Cytovance Biologics
    10.7.7.1. Company Details
    10.7.7.2. Business Overview
    10.7.7.3. Product Portfolio
    10.7.7.4. Financial Insights
    10.7.7.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    10.7.7.6. SWOT Analysis
    10.7.7.7. Geographic Footprint
    10.7.8. Cobra Bio
    10.7.8.1. Company Details
    10.7.8.2. Business Overview
    10.7.8.3. Product Portfolio
    10.7.8.4. Financial Insights
    10.7.8.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    10.7.8.6. SWOT Analysis
    10.7.8.7. Geographic Footprint
    10.7.9. Catalent, Inc.
    10.7.9.1. Company Details
    10.7.9.2. Business Overview
    10.7.9.3. Product Portfolio
    10.7.9.4. Financial Insights
    10.7.9.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    10.7.9.6. SWOT Analysis
    10.7.9.7. Geographic Footprint
    10.7.10. Ajinomoto Althea, Inc.
    10.7.10.1. Company Details
    10.7.10.2. Business Overview
    10.7.10.3. Product Portfolio
    10.7.10.4. Financial Insights
    10.7.10.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    10.7.10.6. SWOT Analysis
    10.7.10.7. Geographic Footprint
- 11. Methodology and Data Source
  - 11.1. Methodology/Research Approach
  - 11.2. Market Size Estimation
  - 11.3. Market Breakdown and Data Triangulation
  - 11.4. Data Source
  - 11.5. Secondary Sources
  - 11.6. Primary Sources
  - 11.7. Appendix
  - 11.8. Disclaimer
List of Tables
- Table 1. Global Vaccine Contract Manufacturing Market Value (US$ Mn), By Vaccine Type, 2019-2033
- Table 2. Global Vaccine Contract Manufacturing Market Value (US$ Mn), By Process, 2019-2033
- Table 3. Global Vaccine Contract Manufacturing Market Value (US$ Mn), By Scale of Operations, 2019-2033
- Table 4. Global Vaccine Contract Manufacturing Market Value (US$ Mn), By End-use, 2019-2033
- Table 5. Global Vaccine Contract Manufacturing Market Value (US$ Mn), By Region, 2019-2033
- Table 6. North America Vaccine Contract Manufacturing Market Value (US$ Mn), By Vaccine Type, 2019-2033
- Table 7. North America Vaccine Contract Manufacturing Market Value (US$ Mn), By Process, 2019-2033
- Table 8. North America Vaccine Contract Manufacturing Market Value (US$ Mn), By Scale of Operations, 2019-2033
- Table 9. North America Vaccine Contract Manufacturing Market Value (US$ Mn), By End-use, 2019-2033
- Table 10. North America Vaccine Contract Manufacturing Market Value (US$ Mn), By Country, 2019-2033
- Table 11. The US Vaccine Contract Manufacturing Market Value (US$ Mn), By Vaccine Type, 2019-2033
- Table 12. The US Vaccine Contract Manufacturing Market Value (US$ Mn), By Process, 2019-2033
- Table 13. The US Vaccine Contract Manufacturing Market Value (US$ Mn), By Scale of Operations, 2019-2033
- Table 14. The US Vaccine Contract Manufacturing Market Value (US$ Mn), By End-use, 2019-2033
- Table 15. Canada Vaccine Contract Manufacturing Market Value (US$ Mn), By Vaccine Type, 2019-2033
- Table 16. Canada Vaccine Contract Manufacturing Market Value (US$ Mn), By Process, 2019-2033
- Table 17. Canada Vaccine Contract Manufacturing Market Value (US$ Mn), By Scale of Operations, 2019-2033
- Table 18. Canada Vaccine Contract Manufacturing Market Value (US$ Mn), By End-use, 2019-2033
- Table 19. Europe Vaccine Contract Manufacturing Market Value (US$ Mn), By Vaccine Type, 2019-2033
- Table 20. Europe Vaccine Contract Manufacturing Market Value (US$ Mn), By Process, 2019-2033
- Table 21. Europe Vaccine Contract Manufacturing Market Value (US$ Mn), By Scale of Operations, 2019-2033
- Table 22. Europe Vaccine Contract Manufacturing Market Value (US$ Mn), By End-use, 2019-2033
- Table 23. Europe Vaccine Contract Manufacturing Market Value (US$ Mn), By Country, 2019-2033
- Table 24. Germany Vaccine Contract Manufacturing Market Value (US$ Mn), By Vaccine Type, 2019-2033
- Table 25. Germany Vaccine Contract Manufacturing Market Value (US$ Mn), By Process, 2019-2033
- Table 26. Germany Vaccine Contract Manufacturing Market Value (US$ Mn), By Scale of Operations, 2019-2033
- Table 27. Germany Vaccine Contract Manufacturing Market Value (US$ Mn), By End-use, 2019-2033
- Table 28. The UK Vaccine Contract Manufacturing Market Value (US$ Mn), By Vaccine Type, 2019-2033
- Table 29. The UK Vaccine Contract Manufacturing Market Value (US$ Mn), By Process, 2019-2033
- Table 30. The UK Vaccine Contract Manufacturing Market Value (US$ Mn), By Scale of Operations, 2019-2033
- Table 31. The UK Vaccine Contract Manufacturing Market Value (US$ Mn), By End-use, 2019-2033
- Table 32. France Vaccine Contract Manufacturing Market Value (US$ Mn), By Vaccine Type, 2019-2033
- Table 33. France Vaccine Contract Manufacturing Market Value (US$ Mn), By Process, 2019-2033
- Table 34. France Vaccine Contract Manufacturing Market Value (US$ Mn), By Scale of Operations, 2019-2033
- Table 35. France Vaccine Contract Manufacturing Market Value (US$ Mn), By End-use, 2019-2033
- Table 36. Spain Vaccine Contract Manufacturing Market Value (US$ Mn), By Vaccine Type, 2019-2033
- Table 37. Spain Vaccine Contract Manufacturing Market Value (US$ Mn), By Process, 2019-2033
- Table 38. Spain Vaccine Contract Manufacturing Market Value (US$ Mn), By Scale of Operations, 2019-2033
- Table 39. Spain Vaccine Contract Manufacturing Market Value (US$ Mn), By End-use, 2019-2033
- Table 40. Italy Vaccine Contract Manufacturing Market Value (US$ Mn), By Vaccine Type, 2019-2033
- Table 41. Italy Vaccine Contract Manufacturing Market Value (US$ Mn), By Process, 2019-2033
- Table 42. Italy Vaccine Contract Manufacturing Market Value (US$ Mn), By Scale of Operations, 2019-2033
- Table 43. Italy Vaccine Contract Manufacturing Market Value (US$ Mn), By End-use, 2019-2033
- Table 44. Russia Vaccine Contract Manufacturing Market Value (US$ Mn), By Vaccine Type, 2019-2033
- Table 45. Russia Vaccine Contract Manufacturing Market Value (US$ Mn), By Process, 2019-2033
- Table 46. Russia Vaccine Contract Manufacturing Market Value (US$ Mn), By Scale of Operations, 2019-2033
- Table 47. Russia Vaccine Contract Manufacturing Market Value (US$ Mn), By End-use, 2019-2033
- Table 48. Netherland Vaccine Contract Manufacturing Market Value (US$ Mn), By Vaccine Type, 2019-2033
- Table 49. Netherland Vaccine Contract Manufacturing Market Value (US$ Mn), By Process, 2019-2033
- Table 50. Netherland Vaccine Contract Manufacturing Market Value (US$ Mn), By Scale of Operations, 2019-2033
- Table 51. Netherland Vaccine Contract Manufacturing Market Value (US$ Mn), By End-use, 2019-2033
- Table 52. Rest of Europe Vaccine Contract Manufacturing Market Value (US$ Mn), By Vaccine Type, 2019-2033
- Table 53. Rest of Europe Vaccine Contract Manufacturing Market Value (US$ Mn), By Process, 2019-2033
- Table 54. Rest of Europe Vaccine Contract Manufacturing Market Value (US$ Mn), By Scale of Operations, 2019-2033
- Table 55. Rest of Europe Vaccine Contract Manufacturing Market Value (US$ Mn), By End-use, 2019-2033
- Table 56. Asia Pacific Vaccine Contract Manufacturing Market Value (US$ Mn), By Vaccine Type, 2019-2033
- Table 57. Asia Pacific Vaccine Contract Manufacturing Market Value (US$ Mn), By Process, 2019-2033
- Table 58. Asia Pacific Vaccine Contract Manufacturing Market Value (US$ Mn), By Scale of Operations, 2019-2033
- Table 59. Asia Pacific Vaccine Contract Manufacturing Market Value (US$ Mn), By End-use, 2019-2033
- Table 60. Asia Pacific Vaccine Contract Manufacturing Market Value (US$ Mn), By Country, 2019-2033
- Table 61. China Vaccine Contract Manufacturing Market Value (US$ Mn), By Vaccine Type, 2019-2033
- Table 62. China Vaccine Contract Manufacturing Market Value (US$ Mn), By Process, 2019-2033
- Table 63. China Vaccine Contract Manufacturing Market Value (US$ Mn), By Scale of Operations, 2019-2033
- Table 64. China Vaccine Contract Manufacturing Market Value (US$ Mn), By End-use, 2019-2033
- Table 65. India Vaccine Contract Manufacturing Market Value (US$ Mn), By Vaccine Type, 2019-2033
- Table 66. India Vaccine Contract Manufacturing Market Value (US$ Mn), By Process, 2019-2033
- Table 67. India Vaccine Contract Manufacturing Market Value (US$ Mn), By Scale of Operations, 2019-2033
- Table 68. India Vaccine Contract Manufacturing Market Value (US$ Mn), By End-use, 2019-2033
- Table 69. Japan Vaccine Contract Manufacturing Market Value (US$ Mn), By Vaccine Type, 2019-2033
- Table 70. Japan Vaccine Contract Manufacturing Market Value (US$ Mn), By Process, 2019-2033
- Table 71. Japan Vaccine Contract Manufacturing Market Value (US$ Mn), By Scale of Operations, 2019-2033
- Table 72. Japan Vaccine Contract Manufacturing Market Value (US$ Mn), By End-use, 2019-2033
- Table 73. South Korea Vaccine Contract Manufacturing Market Value (US$ Mn), By Vaccine Type, 2019-2033
- Table 74. South Korea Vaccine Contract Manufacturing Market Value (US$ Mn), By Process, 2019-2033
- Table 75. South Korea Vaccine Contract Manufacturing Market Value (US$ Mn), By Scale of Operations, 2019-2033
- Table 76. South Korea Vaccine Contract Manufacturing Market Value (US$ Mn), By End-use, 2019-2033
- Table 77. Australia Vaccine Contract Manufacturing Market Value (US$ Mn), By Vaccine Type, 2019-2033
- Table 78. Australia Vaccine Contract Manufacturing Market Value (US$ Mn), By Process, 2019-2033
- Table 79. Australia Vaccine Contract Manufacturing Market Value (US$ Mn), By Scale of Operations, 2019-2033
- Table 80. Australia Vaccine Contract Manufacturing Market Value (US$ Mn), By End-use, 2019-2033
- Table 81. New Zealand Vaccine Contract Manufacturing Market Value (US$ Mn), By Vaccine Type, 2019-2033
- Table 82. New Zealand Vaccine Contract Manufacturing Market Value (US$ Mn), By Process, 2019-2033
- Table 83. New Zealand Vaccine Contract Manufacturing Market Value (US$ Mn), By Scale of Operations, 2019-2033
- Table 84. New Zealand Vaccine Contract Manufacturing Market Value (US$ Mn), By End-use, 2019-2033
- Table 85. Singapore Vaccine Contract Manufacturing Market Value (US$ Mn), By Vaccine Type, 2019-2033
- Table 86. Singapore Vaccine Contract Manufacturing Market Value (US$ Mn), By Process, 2019-2033
- Table 87. Singapore Vaccine Contract Manufacturing Market Value (US$ Mn), By Scale of Operations, 2019-2033
- Table 88. Singapore Vaccine Contract Manufacturing Market Value (US$ Mn), By End-use, 2019-2033
- Table 89. Thailand Vaccine Contract Manufacturing Market Value (US$ Mn), By Vaccine Type, 2019-2033
- Table 90. Thailand Vaccine Contract Manufacturing Market Value (US$ Mn), By Process, 2019-2033
- Table 91. Thailand Vaccine Contract Manufacturing Market Value (US$ Mn), By Scale of Operations, 2019-2033
- Table 92. Thailand Vaccine Contract Manufacturing Market Value (US$ Mn), By End-use, 2019-2033
- Table 93. Vietnam Vaccine Contract Manufacturing Market Value (US$ Mn), By Vaccine Type, 2019-2033
- Table 94. Vietnam Vaccine Contract Manufacturing Market Value (US$ Mn), By Process, 2019-2033
- Table 95. Vietnam Vaccine Contract Manufacturing Market Value (US$ Mn), By Scale of Operations, 2019-2033
- Table 96. Vietnam Vaccine Contract Manufacturing Market Value (US$ Mn), By End-use, 2019-2033
- Table 97. Rest of Asia Pacific Vaccine Contract Manufacturing Market Value (US$ Mn), By Vaccine Type, 2019-2033
- Table 98. Rest of Asia Pacific Vaccine Contract Manufacturing Market Value (US$ Mn), By Process, 2019-2033
- Table 99. Rest of Asia Pacific Vaccine Contract Manufacturing Market Value (US$ Mn), By Scale of Operations, 2019-2033
- Table 100. Rest of Asia Pacific Vaccine Contract Manufacturing Market Value (US$ Mn), By End-use, 2019-2033
- Table 101. Latin America Vaccine Contract Manufacturing Market Value (US$ Mn), By Vaccine Type, 2019-2033
- Table 102. Latin America Vaccine Contract Manufacturing Market Value (US$ Mn), By Process, 2019-2033
- Table 103. Latin America Vaccine Contract Manufacturing Market Value (US$ Mn), By Scale of Operations, 2019-2033
- Table 104. Latin America Vaccine Contract Manufacturing Market Value (US$ Mn), By End-use, 2019-2033
- Table 105. Latin America Vaccine Contract Manufacturing Market Value (US$ Mn), By Country, 2019-2033
- Table 106. Brazil Vaccine Contract Manufacturing Market Value (US$ Mn), By Vaccine Type, 2019-2033
- Table 107. Brazil Vaccine Contract Manufacturing Market Value (US$ Mn), By Process, 2019-2033
- Table 108. Brazil Vaccine Contract Manufacturing Market Value (US$ Mn), By Scale of Operations, 2019-2033
- Table 109. Brazil Vaccine Contract Manufacturing Market Value (US$ Mn), By End-use, 2019-2033
- Table 110. Mexico Vaccine Contract Manufacturing Market Value (US$ Mn), By Vaccine Type, 2019-2033
- Table 111. Mexico Vaccine Contract Manufacturing Market Value (US$ Mn), By Process, 2019-2033
- Table 112. Mexico Vaccine Contract Manufacturing Market Value (US$ Mn), By Scale of Operations, 2019-2033
- Table 113. Mexico Vaccine Contract Manufacturing Market Value (US$ Mn), By End-use, 2019-2033
- Table 114. Rest of Latin America Vaccine Contract Manufacturing Market Value (US$ Mn), By Vaccine Type, 2019-2033
- Table 115. Rest of Latin America Vaccine Contract Manufacturing Market Value (US$ Mn), By Process, 2019-2033
- Table 116. Rest of Latin America Vaccine Contract Manufacturing Market Value (US$ Mn), By Scale of Operations, 2019-2033
- Table 117. Rest of Latin America Vaccine Contract Manufacturing Market Value (US$ Mn), By End-use, 2019-2033
- Table 118. Middle East & Africa Vaccine Contract Manufacturing Market Value (US$ Mn), By Vaccine Type, 2019-2033
- Table 119. Middle East & Africa Vaccine Contract Manufacturing Market Value (US$ Mn), By Process, 2019-2033
- Table 120. Middle East & Africa Vaccine Contract Manufacturing Market Value (US$ Mn), By Scale of Operations, 2019-2033
- Table 121. Middle East & Africa Vaccine Contract Manufacturing Market Value (US$ Mn), By End-use, 2019-2033
- Table 122. Middle East & Africa Vaccine Contract Manufacturing Market Value (US$ Mn), By Country, 2019-2033
- Table 123. South Africa Vaccine Contract Manufacturing Market Value (US$ Mn), By Vaccine Type, 2019-2033
- Table 124. South Africa Vaccine Contract Manufacturing Market Value (US$ Mn), By Process, 2019-2033
- Table 125. South Africa Vaccine Contract Manufacturing Market Value (US$ Mn), By Scale of Operations, 2019-2033
- Table 126. South Africa Vaccine Contract Manufacturing Market Value (US$ Mn), By End-use, 2019-2033
- Table 127. Saudi Arabia Vaccine Contract Manufacturing Market Value (US$ Mn), By Vaccine Type, 2019-2033
- Table 128. Saudi Arabia Vaccine Contract Manufacturing Market Value (US$ Mn), By Process, 2019-2033
- Table 129. Saudi Arabia Vaccine Contract Manufacturing Market Value (US$ Mn), By Scale of Operations, 2019-2033
- Table 130. Saudi Arabia Vaccine Contract Manufacturing Market Value (US$ Mn), By End-use, 2019-2033
- Table 131. UAE Vaccine Contract Manufacturing Market Value (US$ Mn), By Vaccine Type, 2019-2033
- Table 132. UAE Vaccine Contract Manufacturing Market Value (US$ Mn), By Process, 2019-2033
- Table 133. UAE Vaccine Contract Manufacturing Market Value (US$ Mn), By Scale of Operations, 2019-2033
- Table 134. UAE Vaccine Contract Manufacturing Market Value (US$ Mn), By End-use, 2019-2033
- Table 135. Rest of Middle East & Africa Vaccine Contract Manufacturing Market Value (US$ Mn), By Vaccine Type, 2019-2033
- Table 136. Rest of Middle East & Africa Vaccine Contract Manufacturing Market Value (US$ Mn), By Process, 2019-2033
- Table 137. Rest of Middle East & Africa Vaccine Contract Manufacturing Market Value (US$ Mn), By Scale of Operations, 2019-2033
- Table 138. Rest of Middle East & Africa Vaccine Contract Manufacturing Market Value (US$ Mn), By End-use, 2019-2033
List of Figures
- Figure 1. Global Vaccine Contract Manufacturing Market Snapshot: Market Value (US$ Mn), 2019-2033
- Figure 2. Opportunity Map
- Figure 3. Opportunity Orbit
- Figure 4. Regional Market Share and BPS Analysis in Vaccine Contract Manufacturing Market
- Figure 5. Global Vaccine Contract Manufacturing Market Analysis, By Vaccine Type, 2019, 2023 and 2033
- Figure 6. Global Vaccine Contract Manufacturing Market Attractiveness Analysis, By Vaccine Type
- Figure 7. Global Vaccine Contract Manufacturing Market Analysis, By Process, 2019, 2023 and 2033
- Figure 8. Global Vaccine Contract Manufacturing Market Attractiveness Analysis, By Process
- Figure 9. Global Vaccine Contract Manufacturing Market Analysis, By Scale of Operations, 2019, 2023 and 2033
- Figure 10. Global Vaccine Contract Manufacturing Market Attractiveness Analysis, By Scale of Operations
- Figure 11. Global Vaccine Contract Manufacturing Market Analysis, By End-use, 2019, 2023 and 2033
- Figure 12. Global Vaccine Contract Manufacturing Market Attractiveness Analysis, By End-use
- Figure 13. Global Vaccine Contract Manufacturing Market Analysis, By Region, 2019, 2023 and 2033
- Figure 14. Global Vaccine Contract Manufacturing Market Attractiveness Analysis, By Region
- Figure 15. North America Vaccine Contract Manufacturing Market Analysis, By Vaccine Type, 2019, 2023 and 2033
- Figure 16. North America Vaccine Contract Manufacturing Market Attractiveness Analysis, By Vaccine Type
- Figure 17. North America Vaccine Contract Manufacturing Market (US$ Mn), by Inactivated Vaccines, 2019-2033
- Figure 18. North America Vaccine Contract Manufacturing Market (US$ Mn), by Attenuated Vaccines, 2019-2033
- Figure 19. North America Vaccine Contract Manufacturing Market (US$ Mn), by RNA Vaccines, 2019-2033
- Figure 20. North America Vaccine Contract Manufacturing Market (US$ Mn), by Subunit Vaccines, 2019-2033
- Figure 21. North America Vaccine Contract Manufacturing Market (US$ Mn), by Toxoid-based Vaccines, 2019-2033
- Figure 22. North America Vaccine Contract Manufacturing Market Analysis, By Process, 2019, 2023 and 2033
- Figure 23. North America Vaccine Contract Manufacturing Market Attractiveness Analysis, By Process
- Figure 24. North America Vaccine Contract Manufacturing Market (US$ Mn), by Downstream, 2019-2033
- Figure 25. North America Vaccine Contract Manufacturing Market (US$ Mn), by Upstream, 2019-2033
- Figure 26. North America Vaccine Contract Manufacturing Market Analysis, By Scale of Operations, 2019, 2023 and 2033
- Figure 27. North America Vaccine Contract Manufacturing Market Attractiveness Analysis, By Scale of Operations
- Figure 28. North America Vaccine Contract Manufacturing Market (US$ Mn), by Preclinical, 2019-2033
- Figure 29. North America Vaccine Contract Manufacturing Market (US$ Mn), by Clinical, 2019-2033
- Figure 30. North America Vaccine Contract Manufacturing Market (US$ Mn), by Commercial, 2019-2033
- Figure 31. North America Vaccine Contract Manufacturing Market Analysis, By End-use, 2019, 2023 and 2033
- Figure 32. North America Vaccine Contract Manufacturing Market Attractiveness Analysis, By End-use
- Figure 33. North America Vaccine Contract Manufacturing Market (US$ Mn), by Human Use, 2019-2033
- Figure 34. North America Vaccine Contract Manufacturing Market (US$ Mn), by Veterinary, 2019-2033
- Figure 35. North America Vaccine Contract Manufacturing Market Analysis, By Country, 2019, 2023 and 2033
- Figure 36. North America Vaccine Contract Manufacturing Market Attractiveness Analysis, By Country
- Figure 37. Europe Vaccine Contract Manufacturing Market Analysis, By Vaccine Type, 2019, 2023 and 2033
- Figure 38. Europe Vaccine Contract Manufacturing Market Attractiveness Analysis, By Vaccine Type
- Figure 39. Europe Vaccine Contract Manufacturing Market (US$ Mn), by Inactivated Vaccines, 2019-2033
- Figure 40. Europe Vaccine Contract Manufacturing Market (US$ Mn), by Attenuated Vaccines, 2019-2033
- Figure 41. Europe Vaccine Contract Manufacturing Market (US$ Mn), by RNA Vaccines, 2019-2033
- Figure 42. Europe Vaccine Contract Manufacturing Market (US$ Mn), by Subunit Vaccines, 2019-2033
- Figure 43. Europe Vaccine Contract Manufacturing Market (US$ Mn), by Toxoid-based Vaccines, 2019-2033
- Figure 44. Europe Vaccine Contract Manufacturing Market Analysis, By Process, 2019, 2023 and 2033
- Figure 45. Europe Vaccine Contract Manufacturing Market Attractiveness Analysis, By Process
- Figure 46. Europe Vaccine Contract Manufacturing Market (US$ Mn), by Downstream, 2019-2033
- Figure 47. Europe Vaccine Contract Manufacturing Market (US$ Mn), by Upstream, 2019-2033
- Figure 48. Europe Vaccine Contract Manufacturing Market Analysis, By Scale of Operations, 2019, 2023 and 2033
- Figure 49. Europe Vaccine Contract Manufacturing Market Attractiveness Analysis, By Scale of Operations
- Figure 50. Europe Vaccine Contract Manufacturing Market (US$ Mn), by Preclinical, 2019-2033
- Figure 51. Europe Vaccine Contract Manufacturing Market (US$ Mn), by Clinical, 2019-2033
- Figure 52. Europe Vaccine Contract Manufacturing Market (US$ Mn), by Commercial, 2019-2033
- Figure 53. Europe Vaccine Contract Manufacturing Market Analysis, By End-use, 2019, 2023 and 2033
- Figure 54. Europe Vaccine Contract Manufacturing Market Attractiveness Analysis, By End-use
- Figure 55. Europe Vaccine Contract Manufacturing Market (US$ Mn), by Human Use, 2019-2033
- Figure 56. Europe Vaccine Contract Manufacturing Market (US$ Mn), by Veterinary, 2019-2033
- Figure 57. Europe Vaccine Contract Manufacturing Market Analysis, By Country, 2019, 2023 and 2033
- Figure 58. Europe Vaccine Contract Manufacturing Market Attractiveness Analysis, By Country
- Figure 59. Asia Pacific Vaccine Contract Manufacturing Market Analysis, By Vaccine Type, 2019, 2023 and 2033
- Figure 60. Asia Pacific Vaccine Contract Manufacturing Market Attractiveness Analysis, By Vaccine Type
- Figure 61. Asia Pacific Vaccine Contract Manufacturing Market (US$ Mn), by Inactivated Vaccines, 2019-2033
- Figure 62. Asia Pacific Vaccine Contract Manufacturing Market (US$ Mn), by Attenuated Vaccines, 2019-2033
- Figure 63. Asia Pacific Vaccine Contract Manufacturing Market (US$ Mn), by RNA Vaccines, 2019-2033
- Figure 64. Asia Pacific Vaccine Contract Manufacturing Market (US$ Mn), by Subunit Vaccines, 2019-2033
- Figure 65. Asia Pacific Vaccine Contract Manufacturing Market (US$ Mn), by Toxoid-based Vaccines, 2019-2033
- Figure 66. Asia Pacific Vaccine Contract Manufacturing Market Analysis, By Process, 2019, 2023 and 2033
- Figure 67. Asia Pacific Vaccine Contract Manufacturing Market Attractiveness Analysis, By Process
- Figure 68. Asia Pacific Vaccine Contract Manufacturing Market (US$ Mn), by Downstream, 2019-2033
- Figure 69. Asia Pacific Vaccine Contract Manufacturing Market (US$ Mn), by Upstream, 2019-2033
- Figure 70. Asia Pacific Vaccine Contract Manufacturing Market Analysis, By Scale of Operations, 2019, 2023 and 2033
- Figure 71. Asia Pacific Vaccine Contract Manufacturing Market Attractiveness Analysis, By Scale of Operations
- Figure 72. Asia Pacific Vaccine Contract Manufacturing Market (US$ Mn), by Preclinical, 2019-2033
- Figure 73. Asia Pacific Vaccine Contract Manufacturing Market (US$ Mn), by Clinical, 2019-2033
- Figure 74. Asia Pacific Vaccine Contract Manufacturing Market (US$ Mn), by Commercial, 2019-2033
- Figure 75. Asia Pacific Vaccine Contract Manufacturing Market Analysis, By End-use, 2019, 2023 and 2033
- Figure 76. Asia Pacific Vaccine Contract Manufacturing Market Attractiveness Analysis, By End-use
- Figure 77. Asia Pacific Vaccine Contract Manufacturing Market (US$ Mn), by Human Use, 2019-2033
- Figure 78. Asia Pacific Vaccine Contract Manufacturing Market (US$ Mn), by Veterinary, 2019-2033
- Figure 79. Asia Pacific Vaccine Contract Manufacturing Market Analysis, By Country, 2019, 2023 and 2033
- Figure 80. Asia Pacific Vaccine Contract Manufacturing Market Attractiveness Analysis, By Country
- Figure 81. Latin America Vaccine Contract Manufacturing Market Analysis, By Vaccine Type, 2019, 2023 and 2033
- Figure 82. Latin America Vaccine Contract Manufacturing Market Attractiveness Analysis, By Vaccine Type
- Figure 83. Latin America Vaccine Contract Manufacturing Market (US$ Mn), by Inactivated Vaccines, 2019-2033
- Figure 84. Latin America Vaccine Contract Manufacturing Market (US$ Mn), by Attenuated Vaccines, 2019-2033
- Figure 85. Latin America Vaccine Contract Manufacturing Market (US$ Mn), by RNA Vaccines, 2019-2033
- Figure 86. Latin America Vaccine Contract Manufacturing Market (US$ Mn), by Subunit Vaccines, 2019-2033
- Figure 87. Latin America Vaccine Contract Manufacturing Market (US$ Mn), by Toxoid-based Vaccines, 2019-2033
- Figure 88. Latin America Vaccine Contract Manufacturing Market Analysis, By Process, 2019, 2023 and 2033
- Figure 89. Latin America Vaccine Contract Manufacturing Market Attractiveness Analysis, By Process
- Figure 90. Latin America Vaccine Contract Manufacturing Market (US$ Mn), by Downstream, 2019-2033
- Figure 91. Latin America Vaccine Contract Manufacturing Market (US$ Mn), by Upstream, 2019-2033
- Figure 92. Latin America Vaccine Contract Manufacturing Market Analysis, By Scale of Operations, 2019, 2023 and 2033
- Figure 93. Latin America Vaccine Contract Manufacturing Market Attractiveness Analysis, By Scale of Operations
- Figure 94. Latin America Vaccine Contract Manufacturing Market (US$ Mn), by Preclinical, 2019-2033
- Figure 95. Latin America Vaccine Contract Manufacturing Market (US$ Mn), by Clinical, 2019-2033
- Figure 96. Latin America Vaccine Contract Manufacturing Market (US$ Mn), by Commercial, 2019-2033
- Figure 97. Latin America Vaccine Contract Manufacturing Market Analysis, By End-use, 2019, 2023 and 2033
- Figure 98. Latin America Vaccine Contract Manufacturing Market Attractiveness Analysis, By End-use
- Figure 99. Latin America Vaccine Contract Manufacturing Market (US$ Mn), by Human Use, 2019-2033
- Figure 100. Latin America Vaccine Contract Manufacturing Market (US$ Mn), by Veterinary, 2019-2033
- Figure 101. Latin America Vaccine Contract Manufacturing Market Analysis, By Country, 2019, 2023 and 2033
- Figure 102. Latin America Vaccine Contract Manufacturing Market Attractiveness Analysis, By Country
- Figure 103. Middle East & Africa Vaccine Contract Manufacturing Market Analysis, By Vaccine Type, 2019, 2023 and 2033
- Figure 104. Middle East & Africa Vaccine Contract Manufacturing Market Attractiveness Analysis, By Vaccine Type
- Figure 105. Middle East & Africa Vaccine Contract Manufacturing Market (US$ Mn), by Inactivated Vaccines, 2019-2033
- Figure 106. Middle East & Africa Vaccine Contract Manufacturing Market (US$ Mn), by Attenuated Vaccines, 2019-2033
- Figure 107. Middle East & Africa Vaccine Contract Manufacturing Market (US$ Mn), by RNA Vaccines, 2019-2033
- Figure 108. Middle East & Africa Vaccine Contract Manufacturing Market (US$ Mn), by Subunit Vaccines, 2019-2033
- Figure 109. Middle East & Africa Vaccine Contract Manufacturing Market (US$ Mn), by Toxoid-based Vaccines, 2019-2033
- Figure 110. Middle East & Africa Vaccine Contract Manufacturing Market Analysis, By Process, 2019, 2023 and 2033
- Figure 111. Middle East & Africa Vaccine Contract Manufacturing Market Attractiveness Analysis, By Process
- Figure 112. Middle East & Africa Vaccine Contract Manufacturing Market (US$ Mn), by Downstream, 2019-2033
- Figure 113. Middle East & Africa Vaccine Contract Manufacturing Market (US$ Mn), by Upstream, 2019-2033
- Figure 114. Middle East & Africa Vaccine Contract Manufacturing Market Analysis, By Scale of Operations, 2019, 2023 and 2033
- Figure 115. Middle East & Africa Vaccine Contract Manufacturing Market Attractiveness Analysis, By Scale of Operations
- Figure 116. Middle East & Africa Vaccine Contract Manufacturing Market (US$ Mn), by Preclinical, 2019-2033
- Figure 117. Middle East & Africa Vaccine Contract Manufacturing Market (US$ Mn), by Clinical, 2019-2033
- Figure 118. Middle East & Africa Vaccine Contract Manufacturing Market (US$ Mn), by Commercial, 2019-2033
- Figure 119. Middle East & Africa Vaccine Contract Manufacturing Market Analysis, By End-use, 2019, 2023 and 2033
- Figure 120. Middle East & Africa Vaccine Contract Manufacturing Market Attractiveness Analysis, By End-use
- Figure 121. Middle East & Africa Vaccine Contract Manufacturing Market (US$ Mn), by Human Use, 2019-2033
- Figure 122. Middle East & Africa Vaccine Contract Manufacturing Market (US$ Mn), by Veterinary, 2019-2033
- Figure 123. Middle East & Africa Vaccine Contract Manufacturing Market Analysis, By Country, 2019, 2023 and 2033
- Figure 124. Middle East & Africa Vaccine Contract Manufacturing Market Attractiveness Analysis, By Country
- PRA Health Sciences
- Pharmaceutical Product Development, LLC
- Moderna
- Merck KGaA Company Profile
- IDT Biologika GmbH
- ICON plc.
- Cytovance Biologics
- Cobra Bio
- Catalent, Inc.
- Ajinomoto Althea, Inc.
Settings

Related Reports

Our Clients

✖

Request a Sample Report

We'll get back to you as quickly as possible

	Single User $6,000 $3,999 USD / per unit save 24%	Multi User $8,000 $5,999 USD / per unit save 28%	Corporate User $10,000 $6,999 USD / per unit save 32%
e-Access
Report Library Access
Data Set (Excel)
Print
Company Profile Library Access
Interactive Dashboard
Free Custumization	No	up to 10 hrs work	up to 30 hrs work
Accessibility	1 User	2-5 User	Unlimited
Analyst Support	up to 20 hrs	up to 40 hrs	up to 50 hrs
Benefit	Up to 20% off on next purchase	Up to 25% off on next purchase	Up to 30% off on next purchase
	Buy Now ($ 3,999)	Buy Now ($ 5,999)	Buy Now ($ 6,999)

Table of Contents

List of Tables

List of Figures

Related Reports

Our Clients